LongRVXer

Yeah - I am 3 months away from my ninth anniversary long on RVX - still waiting for revenues.

Everything is on the table with this Covid-19 trial. IMO it is Covid EUA or bust. It probably took almost all of the corporate resources over the last two years to get this trial up and running. RVX has ~40 employees - a small staff to put together an FDA trial in multiple countries (I live and work near the Merck complex in West Point, PA - they have ~ 10,000 employees working at the West Point facility which is not their corporate facility-located in Rahway, NJ). The product was relabled for Brazil and Morocco. They shifted gears from BOM to Covid. There are thousands of compounds in line for Covid trials. The regulatory approval process is onerous. The variants keep changing the target. Hopefully they got the trial design right and they will prove the science. It all takes time and we are nearing the end. If they are not successful with this Covid trial, their resources will be gone and BOMII will be a total equity reset - significant dilution. News should be leaking out soon.

On another front - DM promised a financial update at his last presentation before Christmas - how about it? The annual calendar year financials should also be out shortly.

It is high time for this science to generate some revenues.

Chicagoest